This is officially becoming a trend: Springer is pulling another 64 articles from 10 journals after finding evidence of faked peer reviews, bringing the total number of retractions from the phenomenon north of 230.
Given that there have been about 1,500 papers retracted overall since 2012, when we first reported on the phenomenon, faked reviews have been responsible for about 15% of all retractions in the past three years.
This isn’t the first time Springer has faced the issue. As owner of the BioMed Central journals, it issued 43 retractions for faked reviews earlier this year.
In a statement, the publisher explains how the latest round of retractions came to light: Continue reading 64 more papers retracted for fake reviews, this time from Springer journals
Two papers about the molecular underpinnings of lung damage are being retracted following an investigation at Oita University in Japan, which revealed that images from both papers had been used to depict “different experimental conditions” in a third paper (which has not been retracted).
It’s not clear which of the authors were the subject of the investigation. The two retracted papers, “Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury” in the Journal of Anesthesia and “Coexpression of HSP47 Gene and Type I and Type III Collagen Genes in LPS-Induced Pulmonary Fibrosis in Rats” in Lung, both originally published in 2007, share the same first author — Satoshi Hagiwara, whose affiliation is listed as the Department of Brain and Nerve Science, Anesthesiology, Oita University Faculty of Medicine. The papers have been cited 13 times and 12 times, respectively, according to Thomson Scientific’s Web of Knowledge. Hagiwara is also the first author on the third paper that contains the duplicated images.
The first retraction notice reads:
Continue reading “A decision of misconduct was reached”: Two lung papers expire